© Copyright 2026 American Medical Association. All rights reserved.
Hematopoietic progenitor cell (HPC) transplantation, commonly known as hematopoietic stem cell (HSC) transplantation, is a medical procedure that involves the infusion of progenitor cells into a recipient's bloodstream. These progenitor cells, which are essential for the formation of blood cells, can be sourced from various locations within the body, including bone marrow, peripheral blood, or umbilical cord blood. In the context of CPT® Code 38241, the transplantation is classified as autologous, meaning that the stem cells are harvested from the patient themselves, rather than from a donor (which would be termed allogeneic). Prior to the transplantation, the patient undergoes a preparatory phase that may include myeloablative or immunosuppressive conditioning to prepare the body for the incoming cells. The harvested progenitor cells are typically frozen and stored until the transplantation procedure is performed. During the actual procedure, these cells are thawed, prepared, and then infused intravenously into the patient, facilitating the restoration of healthy blood cell production. It is important to note that for allogeneic transplantation, a different code (CPT® Code 38240) is utilized, and if multiple donors are involved, each donor's contribution is reported separately using the same code. CPT® Code 38241 specifically pertains to the autologous transplantation of hematopoietic progenitor cells.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.